Covariance and variance evaluations of two estimators for drug-placebo difference in a trial with sequential parallel design
DOI10.1080/03610926.2016.1205613zbMATH Open1377.62205OpenAlexW2508607780MaRDI QIDQ4588906FDOQ4588906
Authors: Yanning Liu
Publication date: 3 November 2017
Published in: Communications in Statistics: Theory and Methods (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1080/03610926.2016.1205613
Recommendations
- Analysis of covariance in randomized trials: more precision and valid confidence intervals, without model assumptions
- On Variance Estimation in Crossover Designs
- Robust design in a two treatment comparison in the presence of a covariate
- A generalized correlation coefficient for the general two-treatment crossover design
- Covariance identity for multinomial trials.
Applications of statistics to biology and medical sciences; meta analysis (62P10) Analysis of variance and covariance (ANOVA) (62J10) Sequential statistical design (62L05)
Cited In (5)
- Covariance identity for multinomial trials.
- Analysis of Covariance in Parallel-Group Clinical Trials with Pretreatment Baselines
- Placebo Response as a Latent Characteristic: Application to Analysis of Sequential Parallel Comparison Design Studies
- Title not available (Why is that?)
- On the efficiency of nonparametric variance estimation in sequential dose-finding
This page was built for publication: Covariance and variance evaluations of two estimators for drug-placebo difference in a trial with sequential parallel design
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4588906)